A two-part study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat oral doses of GSK256073A, in a randomized, single-blind, dose escalation study in healthy adult subjects

Trial Profile

A two-part study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat oral doses of GSK256073A, in a randomized, single-blind, dose escalation study in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs GSK 256073 (Primary)
  • Indications Dyslipidaemias
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 18 Jun 2008 Status changed from initiated to completed as reported by ClinicalTrials.gov.
    • 17 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top